Biogen Inc. buy hoffi69
Start price
08.05.12
/
50%
€101.61
Target price
23.10.12
€110.00
Performance (%)
7.22%
End price
23.10.12
€108.95
Summary
This prediction ended on 23.10.12 with a price of €108.95. With a performance of 7.22%, the BUY prediction by hoffi69 for Biogen Inc. closed with a slight gain. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 6.258% | 6.258% | 10.821% | -36.992% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt sich auch in unruhigen Börsenzeiten einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)